Growing demand for personalized medicine is encouraging pharmaceutical manufacturers to develop patient-specific oncology treatment strategies. HER2 antibodies are becoming an important part of biomarker-driven cancer management. Market Overview The HER2 Antibodies Market is expected to register a CAGR of 5.1% from 2025 to 2031. The market valuation is reported as US$ XX million in...